Evidence map›Paper›PMID 23273106›Full record

Trial reportPain2013

Amygdala activity contributes to the dissociative effect of cannabis on pain perception.

Michael C Lee, Markus Ploner, Katja Wiech, Ulrike Bingel, Vishvarani Wanigasekera, Jonathan Brooks, David K Menon, Irene Tracey

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pain, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 15 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 15 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cannabis-based medicines and medical cannabis for adults with cancer pain.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Cannabis-based medicines for chronic neuropathic pain in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  13. Pooled it
  14. Cannabinoids for fibromyalgia.The Cochrane database of systematic reviews · 2016
    Pooled it
  15. Pooled it
  16. Effects and safety of a CBD-richFrontiers in pharmacology · 2025
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Effects of oral ΔEuropean journal of clinical pharmacology · 2017
    Trial

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Michael C LeeCentre for Functional MRI of the Brain (FMRIB), Department of Clinical Neurology and Nuffield Department of Clinical Neurosciences, Division of Anaesthesia, University of Oxford, Oxford, UK Department of Neurology, Technische Universtität München, Munich, Germany NeuroImage Nord, Department of Neurology, University Medical Center, Hamburg-Eppendorf, Germany Department of Medicine, Division of Anaesthesia, University of Cambridge, Cambridge, UK.
Markus Ploner
Katja Wiech
Ulrike Bingel
Vishvarani Wanigasekera
Jonathan Brooks
David K Menon
Irene Tracey
University of Oxford · GBUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DEUniversity of Cambridge · GB

Funding

Medical Research Council G0601340Medical Research Council G0700238Medical Research Council G0700399Medical Research Council RG47261-RUAG/020Wellcome Trust
6 · The paper itself

Abstract

Cannabis is reported to be remarkably effective for the relief of otherwise intractable pain. However, the bases for pain relief afforded by this psychotropic agent are debatable. Nonetheless, the frontal-limbic distribution of cannabinoid receptors in the brain suggests that cannabis may target preferentially the affective qualities of pain. This central mechanism of action may be relevant to cannabinoid analgesia in humans, but has yet to be demonstrated. Here, we employed functional magnetic resonance imaging to investigate the effects of delta-9-tetrahydrocannabinol (THC), a naturally occurring cannabinoid, on brain activity related to cutaneous ongoing pain and hyperalgesia that were temporarily induced by capsaicin in healthy volunteers. On average, THC reduced the reported unpleasantness, but not the intensity of ongoing pain and hyperalgesia: the specific analgesic effect on hyperalgesia was substantiated by diminished activity in the anterior mid cingulate cortex. In individuals, the drug-induced reduction in the unpleasantness of hyperalgesia was positively correlated with right amygdala activity. THC also reduced functional connectivity between the amygdala and primary sensorimotor areas during the ongoing-pain state. Critically, the reduction in sensory-limbic functional connectivity was positively correlated with the difference in drug effects on the unpleasantness and the intensity of ongoing pain. Peripheral mechanisms alone cannot account for the dissociative effects of THC on the pain that was observed. Instead, the data reveal that amygdala activity contributes to interindividual response to cannabinoid analgesia, and suggest that dissociative effects of THC in the brain are relevant to pain relief in humans.

Indexed as

AdultAmygdalaAnalgesics, Non-NarcoticAntigens, ViralCapsaicinCross-Over StudiesDissociative DisordersDouble-Blind MethodDronabinolHeart RateHumansHyperalgesiaMalePain PerceptionPlacebosPsychomotor PerformanceAnalgesics, Non-NarcoticAntigens, ViralCapsaicinDronabinolFMR antigenPlacebosSensory System Agents

Identifiers

PMID23273106
PMCPMC3549497
OpenAlexW2078355602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.